Concentrix (CNXC) Financials

$50.15 -3.01 (-5.66%)

Closing price 06/20/2025 04:00 PM Eastern

Extended Trading

$50.16 +0.01 (+0.02%)

As of 06/20/2025 07:52 PM Eastern

Annual Income Statements for Concentrix

This table shows Concentrix's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024
Period end date	11/30/2019	11/30/2020	11/30/2021	11/30/2022	11/30/2023	11/30/2024
Net Income / (Loss) Attributable to Common Shareholders	117	165	406	435	314	251
Consolidated Net Income / (Loss)	117	165	406	436	314	251
Net Income / (Loss) Continuing Operations	117	165	406	436	314	251
Total Pre-Tax Income	204	268	556	605	408	299
Total Operating Income	294	309	572	640	661	596
Total Gross Profit	1,748	1,662	1,969	2,257	2,578	3,449
Total Revenue	4,708	4,720	5,587	6,324	7,115	9,619
Operating Revenue	4,708	4,720	5,587	6,324	7,115	9,619
Total Cost of Revenue	2,959	3,058	3,618	4,067	4,537	6,170
Operating Cost of Revenue	2,959	3,058	3,618	4,067	4,537	6,170
Total Operating Expenses	1,454	1,353	1,397	1,617	1,917	2,853
Selling, General & Admin Expense	1,454	1,353	1,397	1,617	1,917	2,853
Total Other Income / (Expense), net	-90	-41	-17	-35	-253	-297
Interest Expense	92	48	23	70	201	322
Other Income / (Expense), net	2.28	7.45	6.35	35	-52	25
Income Tax Expense	87	103	150	169	94	48
Net Income / (Loss) Attributable to Noncontrolling Interest	-	0.00	0.00	0.59	0.00	0.00
Basic Earnings per Share	$2.27	$3.19	$7.78	$8.34	$5.72	$3.72
Weighted Average Basic Shares Outstanding	51.60M	51.60M	51.36M	51.35M	53.80M	64.98M
Diluted Earnings per Share	$2.27	$3.19	$7.70	$8.28	$5.70	$3.71
Weighted Average Diluted Shares Outstanding	51.60M	51.60M	51.91M	51.74M	54.01M	65.07M
Weighted Average Basic & Diluted Shares Outstanding	-	-	52.32M	52.07M	66.33M	64.40M

This table shows Concentrix's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	8/31/2022	11/30/2022	2/28/2023	5/31/2023	8/31/2023	11/30/2023	2/29/2024	5/31/2024	8/31/2024	11/30/2024	2/28/2025
Net Income / (Loss) Attributable to Common Shareholders	107	105	88	79	78	69	52	67	17	116	70
Consolidated Net Income / (Loss)	107	105	88	79	78	69	52	67	17	116	70
Net Income / (Loss) Continuing Operations	107	105	88	79	78	69	52	67	17	116	70
Total Pre-Tax Income	149	163	118	106	107	77	73	87	26	113	101
Total Operating Income	158	178	156	163	162	180	148	150	153	145	169
Total Gross Profit	567	593	581	580	594	823	857	858	864	871	856
Total Revenue	1,580	1,641	1,636	1,615	1,633	2,231	2,403	2,381	2,387	2,448	2,372
Operating Revenue	1,580	1,641	1,636	1,615	1,633	2,231	2,403	2,381	2,387	2,448	2,372
Total Cost of Revenue	1,013	1,047	1,055	1,034	1,039	1,408	1,546	1,523	1,523	1,577	1,516
Operating Cost of Revenue	1,013	1,047	1,055	1,034	1,039	1,408	1,546	1,523	1,523	1,577	1,516
Total Operating Expenses	409	415	425	418	431	642	708	707	711	726	687
Selling, General & Admin Expense	409	415	425	418	431	642	708	707	711	726	687
Total Other Income / (Expense), net	-8.19	-15	-38	-57	-55	-103	-76	-63	-127	-32	-68
Interest Expense	20	28	34	47	49	71	82	82	81	76	73
Other Income / (Expense), net	12	13	-3.71	-9.38	-6.17	-33	6.82	19	-46	44	4.92
Income Tax Expense	42	58	30	27	29	7.62	21	20	9.79	-2.74	31
Basic Earnings per Share	$2.05	$2.02	$1.69	$1.51	$1.50	$1.02	$0.76	$0.98	$0.25	$1.73	$1.04
Weighted Average Basic Shares Outstanding	51.19M	51.35M	51.15M	51.18M	51.06M	53.80M	65.66M	65.27M	64.66M	64.98M	64.04M
Diluted Earnings per Share	$2.04	$2.01	$1.68	$1.51	$1.49	$1.02	$0.76	$0.98	$0.25	$1.72	$1.04
Weighted Average Diluted Shares Outstanding	51.55M	51.74M	51.48M	51.39M	51.21M	54.01M	65.79M	65.33M	64.75M	65.07M	64.07M
Weighted Average Basic & Diluted Shares Outstanding	51.67M	52.07M	52.06M	52.05M	66.60M	66.33M	65.99M	65.33M	64.82M	64.40M	63.88M

This table details how cash moves in and out of Concentrix's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024
Period end date	11/30/2019	11/30/2020	11/30/2021	11/30/2022	11/30/2023	11/30/2024
Net Change in Cash & Equivalents	138	73	27	-26	359	-69
Net Cash From Operating Activities	450	508	514	601	678	667
Net Cash From Continuing Operating Activities	448	508	514	601	678	667
Net Income / (Loss) Continuing Operations	117	165	406	436	314	251
Consolidated Net Income / (Loss)	117	165	406	436	314	251
Depreciation Expense	139	129	140	147	173	247
Amortization Expense	167	147	139	164	221	484
Non-Cash Adjustments To Reconcile Net Income	52	49	21	48	86	117
Changes in Operating Assets and Liabilities, net	-27	18	-192	-194	-117	-431
Net Cash From Investing Activities	-151	-109	-79	-1,839	-2,109	-244
Net Cash From Continuing Investing Activities	-121	-109	-79	-1,839	-2,095	-244
Purchase of Property, Plant & Equipment	-111	-171	-149	-140	-181	-239
Acquisitions	-9.43	-5.56	-3.28	-1,698	-1,914	-5.50
Purchase of Investments	-	0.00	0.00	-1.00	0.00	0.00
Other Investing Activities, net	-	68	-	-	-	0.00
Net Cash From Financing Activities	-340	-335	-402	1,238	1,803	-493
Net Cash From Continuing Financing Activities	-192	-335	-402	1,238	1,816	-493
Repayment of Debt	0.00	-1,485	-1,661	-2,514	-2,442	-2,407
Repurchase of Common Equity	-	0.00	-25	-123	-64	-136
Payment of Dividends	-	0.00	-13	-53	-63	-84
Issuance of Debt	0.00	1,150	1,316	3,931	4,396	2,197
Other Financing Activities, net	-192	0.00	-19	-2.89	-10	-63
Cash Interest Paid	-	0.00	21	68	143	282
Cash Income Taxes Paid	-	77	160	144	217	298

This table details how cash moves in and out of Concentrix's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	8/31/2022	11/30/2022	2/28/2023	5/31/2023	8/31/2023	11/30/2023	2/29/2024	5/31/2024	8/31/2024	11/30/2024	2/28/2025
Net Change in Cash & Equivalents	14	-21	33	-28	1,962	-1,608	-99	-20	44	5.42	46
Net Cash From Operating Activities	153	236	104	133	211	229	-47	238	192	284	1.41
Net Cash From Continuing Operating Activities	153	236	103	134	211	229	-47	238	192	284	1.41
Net Income / (Loss) Continuing Operations	107	105	88	79	78	69	52	67	17	116	70
Consolidated Net Income / (Loss)	107	105	88	79	78	69	52	67	17	116	70
Depreciation Expense	37	37	38	38	38	59	68	61	60	59	55
Amortization Expense	42	43	39	47	34	101	122	129	123	116	112
Non-Cash Adjustments To Reconcile Net Income	5.44	7.72	14	34	16	23	24	23	29	36	34
Changes in Operating Assets and Liabilities, net	-38	43	-76	-64	46	-23	-313	-41	-36	-42	-269
Net Cash From Investing Activities	-166	-36	-40	-32	-44	-1,994	-61	-60	-63	-61	-51
Net Cash From Continuing Investing Activities	-166	-36	-40	-32	-44	-1,979	-61	-60	-63	-61	-51
Purchase of Property, Plant & Equipment	-26	-43	-40	-32	-44	-65	-56	-60	-63	-60	-51
Acquisitions	-140	7.19	0.00	-	-	-1,914	-4.50	-0.00	-	-1.00	-0.66
Net Cash From Financing Activities	41	-218	-35	-127	1,798	166	14	-198	-85	-224	102
Net Cash From Continuing Financing Activities	41	-218	-35	-127	1,798	180	14	-198	-85	-224	102
Repayment of Debt	-499	-564	-422	-418	-664	-938	-533	-676	-582	-615	-507
Repurchase of Common Equity	-51	-14	-10	-4.94	-27	-22	-22	-41	-39	-34	-26
Payment of Dividends	-13	-14	-14	-14	-14	-21	-21	-20	-20	-23	-22
Issuance of Debt	603	380	418	310	2,502	1,166	628	555	548	466	683
Other Financing Activities, net	1.50	-6.67	-5.71	0.45	1.38	-6.14	-38	-15	8.24	-18	-24
Effect of Exchange Rate Changes	-12	-2.71	2.80	-1.44	-4.07	-9.71	-5.54	-0.43	-0.37	-	-6.58

This table presents Concentrix's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Period end date	11/30/2020	11/30/2021	11/30/2022	11/30/2023	11/30/2024
Total Assets	5,178	5,046	6,670	12,492	11,991
Total Current Assets	1,423	1,543	1,754	2,859	2,842
Cash & Equivalents	153	182	145	295	241
Accounts Receivable	1,081	1,208	1,390	1,889	1,927
Other Current Assets	189	153	218	674	675
Plant, Property, & Equipment, net	452	407	404	749	715
Total Noncurrent Assets	3,303	3,096	4,512	8,884	8,434
Goodwill	1,836	1,814	2,904	5,079	4,987
Intangible Assets	799	656	986	2,805	2,287
Noncurrent Deferred & Refundable Income Taxes	47	48	49	72	218
Other Noncurrent Operating Assets	620	579	573	929	942
Total Liabilities & Shareholders' Equity	5,178	5,046	6,670	12,492	11,991
Total Liabilities	2,875	2,426	3,974	8,349	7,952
Total Current Liabilities	1,009	968	1,132	2,074	1,996
Short-Term Debt	34	0.00	0.00	2.31	2.52
Accounts Payable	141	129	161	244	210
Accrued Expenses	371	352	395	1,016	977
Current Deferred & Payable Income Tax Liabilities	21	34	69	81	100
Current Employee Benefit Liabilities	420	453	507	731	707
Total Noncurrent Liabilities	1,867	1,458	2,842	6,274	5,956
Long-Term Debt	1,111	802	2,224	4,940	4,733
Noncurrent Deferred & Payable Income Tax Liabilities	154	109	105	414	313
Other Noncurrent Operating Liabilities	602	546	512	921	910
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,302	2,620	2,696	4,143	4,040
Total Preferred & Common Equity	2,302	2,620	2,696	4,143	4,040
Preferred Stock	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,302	2,620	2,696	4,143	4,040
Common Stock	0.00	2,356	2,428	3,583	3,684
Retained Earnings	0.00	392	774	1,024	1,192
Treasury Stock	0.00	-57	-191	-272	-421
Accumulated Other Comprehensive Income / (Loss)	-3.81	-71	-316	-192	-414

This table presents Concentrix's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Period end date	8/31/2022	2/28/2023	5/31/2023	8/31/2023	2/29/2024	5/31/2024	8/31/2024	2/28/2025
Total Assets	6,750	6,623	6,560	8,450	12,243	12,079	12,208	11,895
Total Current Assets	1,717	1,748	1,752	3,702	2,782	2,716	2,850	2,961
Cash & Equivalents	176	178	153	2,113	235	207	246	308
Accounts Receivable	1,355	1,382	1,394	1,379	1,928	1,872	1,936	2,015
Other Current Assets	186	188	205	210	619	637	668	638
Plant, Property, & Equipment, net	390	399	394	406	730	728	733	678
Total Noncurrent Assets	4,642	4,476	4,413	4,341	8,731	8,635	8,625	8,257
Goodwill	2,972	2,905	2,904	2,897	5,031	5,026	5,084	4,936
Intangible Assets	1,026	949	911	873	2,673	2,564	2,483	2,161
Noncurrent Deferred & Refundable Income Taxes	60	45	45	48	76	112	115	236
Other Noncurrent Operating Assets	585	577	554	523	951	933	943	924
Total Liabilities & Shareholders' Equity	6,750	6,623	6,560	8,450	12,243	12,079	12,208	11,895
Total Liabilities	4,103	3,823	3,706	5,546	8,141	7,995	8,039	7,861
Total Current Liabilities	1,028	994	1,007	1,046	1,783	1,766	1,812	1,792
Short-Term Debt	6.25	0.00	0.00	0.00	2.71	1.59	2.86	0.46
Accounts Payable	114	142	149	138	202	202	211	158
Accrued Expenses	397	393	400	398	924	936	933	920
Current Deferred & Payable Income Tax Liabilities	45	71	41	39	60	39	31	128
Current Employee Benefit Liabilities	465	389	418	470	594	589	635	585
Total Noncurrent Liabilities	3,075	2,829	2,698	4,500	6,358	6,229	6,227	6,069
Long-Term Debt	2,401	2,220	2,131	3,973	5,034	4,924	4,909	4,901
Noncurrent Deferred & Payable Income Tax Liabilities	159	100	77	59	386	386	378	294
Other Noncurrent Operating Liabilities	515	509	490	468	938	919	940	874
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,647	2,801	2,854	2,904	4,102	4,083	4,169	4,034
Total Preferred & Common Equity	2,647	2,801	2,854	2,904	4,102	4,083	4,169	4,034
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,647	2,801	2,854	2,904	4,102	4,083	4,169	4,034
Common Stock	2,416	2,447	2,459	2,472	3,606	3,628	3,654	3,712
Retained Earnings	683	848	912	976	1,056	1,102	1,099	1,240
Treasury Stock	-167	-209	-214	-242	-296	-336	-376	-449
Accumulated Other Comprehensive Income / (Loss)	-285	-286	-303	-302	-264	-310	-208	-468

This table displays calculated financial ratios and metrics derived from Concentrix's official financial filings.

Metric	2019	2020	2021	2022	2023	2024
Period end date	11/30/2019	11/30/2020	11/30/2021	11/30/2022	11/30/2023	11/30/2024
Growth Metrics	-	-	-	-	-	-
Revenue Growth	0.00%	0.25%	18.38%	13.20%	12.49%	35.20%
EBITDA Growth	0.00%	-1.60%	44.67%	15.02%	1.75%	34.74%
EBIT Growth	0.00%	6.61%	83.03%	16.65%	-9.75%	1.95%
NOPAT Growth	0.00%	12.60%	119.93%	10.34%	10.29%	-1.53%
Net Income Growth	0.00%	40.67%	146.09%	7.41%	-27.96%	-19.95%
EPS Growth	0.00%	40.53%	141.38%	7.53%	-31.16%	-34.91%
Operating Cash Flow Growth	0.00%	12.87%	1.29%	16.83%	12.87%	-1.55%
Free Cash Flow Firm Growth	0.00%	0.00%	115.21%	-327.42%	-226.64%	121.55%
Invested Capital Growth	0.00%	0.00%	-1.65%	47.36%	84.09%	-2.90%
Revenue Q/Q Growth	0.00%	0.00%	3.06%	2.83%	9.04%	2.31%
EBITDA Q/Q Growth	0.00%	0.00%	3.96%	4.44%	3.79%	4.35%
EBIT Q/Q Growth	0.00%	0.00%	6.49%	4.97%	-6.59%	7.14%
NOPAT Q/Q Growth	0.00%	0.00%	16.34%	-2.36%	9.06%	1.73%
Net Income Q/Q Growth	0.00%	0.00%	17.19%	-4.21%	-10.15%	22.51%
EPS Q/Q Growth	0.00%	0.00%	16.84%	-4.06%	-14.80%	23.26%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	13.97%	9.80%	-0.94%	9.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	4.85%	-704.75%	121.13%
Invested Capital Q/Q Growth	0.00%	0.00%	-1.13%	-2.11%	84.50%	-3.39%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	37.14%	35.21%	35.25%	35.69%	36.23%	35.86%
EBITDA Margin	12.80%	12.56%	15.35%	15.60%	14.11%	14.06%
Operating Margin	6.25%	6.54%	10.25%	10.12%	9.30%	6.20%
EBIT Margin	6.30%	6.70%	10.36%	10.67%	8.56%	6.46%
Profit (Net Income) Margin	2.49%	3.49%	7.26%	6.89%	4.41%	2.61%
Tax Burden Percent	57.32%	61.52%	72.99%	72.01%	76.88%	83.94%
Interest Burden Percent	68.92%	84.72%	96.02%	89.62%	67.01%	48.18%
Effective Tax Rate	42.68%	38.48%	27.01%	27.99%	23.12%	16.06%
Return on Invested Capital (ROIC)	0.00%	11.53%	12.79%	11.50%	7.50%	5.78%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	6.46%	11.27%	9.63%	1.71%	0.32%
Return on Net Nonoperating Assets (RNNOA)	0.00%	2.79%	3.69%	4.89%	1.68%	0.36%
Return on Equity (ROE)	0.00%	14.32%	16.48%	16.39%	9.18%	6.14%
Cash Return on Invested Capital (CROIC)	0.00%	-188.47%	14.45%	-26.79%	-51.70%	8.73%
Operating Return on Assets (OROA)	0.00%	6.11%	11.32%	11.52%	6.36%	5.07%
Return on Assets (ROA)	0.00%	3.18%	7.93%	7.44%	3.28%	2.05%
Return on Common Equity (ROCE)	0.00%	14.32%	16.48%	16.39%	9.18%	6.14%
Return on Equity Simple (ROE_SIMPLE)	0.00%	7.16%	15.48%	16.16%	7.57%	6.22%
Net Operating Profit after Tax (NOPAT)	169	190	418	461	508	501
NOPAT Margin	3.58%	4.02%	7.48%	7.29%	7.15%	5.20%
Net Nonoperating Expense Percent (NNEP)	0.00%	5.07%	1.51%	1.88%	5.79%	5.46%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	9.37%	5.60%	5.70%
Cost of Revenue to Revenue	62.86%	64.79%	64.75%	64.31%	63.77%	64.14%
SG&A Expenses to Revenue	30.89%	28.66%	25.01%	25.57%	26.94%	29.66%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	30.89%	28.66%	25.01%	25.57%	26.94%	29.66%
Earnings before Interest and Taxes (EBIT)	297	316	579	675	609	621
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	602	593	858	986	1,004	1,352
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	3.21	2.27	1.48	0.72
Price to Tangible Book Value (P/TBV)	0.00	0.00	55.60	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	1.50	0.97	0.86	0.30
Price to Earnings (P/E)	0.00	0.00	20.73	14.07	19.54	11.60
Dividend Yield	0.00%	0.00%	0.16%	0.87%	1.22%	2.76%
Earnings Yield	0.00%	0.00%	4.82%	7.11%	5.12%	8.62%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	2.79	1.72	1.23	0.87
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	1.62	1.30	1.52	0.77
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	10.53	8.31	10.74	5.48
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	15.60	12.15	17.69	11.93
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	21.61	17.79	21.20	14.80
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	17.56	13.65	15.90	11.10
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	19.12	0.00	0.00	9.80
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.00	0.50	0.31	0.83	1.19	1.17
Long-Term Debt to Equity	0.00	0.48	0.31	0.83	1.19	1.17
Financial Leverage	0.00	0.43	0.33	0.51	0.98	1.12
Leverage Ratio	0.00	2.25	2.08	2.20	2.80	2.99
Compound Leverage Factor	0.00	1.91	1.99	1.98	1.88	1.44
Debt to Total Capital	0.00%	33.22%	23.44%	45.21%	54.40%	53.96%
Short-Term Debt to Total Capital	0.00%	0.98%	0.00%	0.00%	0.03%	0.03%
Long-Term Debt to Total Capital	0.00%	32.24%	23.44%	45.21%	54.37%	53.94%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	66.78%	76.56%	54.79%	45.60%	46.04%
Debt to EBITDA	0.00	1.93	0.94	2.26	4.92	3.50
Net Debt to EBITDA	0.00	1.67	0.72	2.11	4.63	3.32
Long-Term Debt to EBITDA	0.00	1.87	0.94	2.26	4.92	3.50
Debt to NOPAT	0.00	6.03	1.92	4.83	9.72	9.46
Net Debt to NOPAT	0.00	5.22	1.48	4.51	9.14	8.98
Long-Term Debt to NOPAT	0.00	5.85	1.92	4.83	9.72	9.45
Altman Z-Score	0.00	0.00	3.81	2.48	1.36	1.42
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	0.00	1.41	1.59	1.55	1.38	1.42
Quick Ratio	0.00	1.22	1.44	1.36	1.05	1.09
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-3,105	472	-1,074	-3,507	756
Operating Cash Flow to CapEx	404.72%	296.28%	344.90%	429.03%	375.56%	279.56%
Free Cash Flow to Firm to Interest Expense	0.00	-64.26	20.48	-15.32	-17.45	2.35
Operating Cash Flow to Interest Expense	4.88	10.51	22.31	8.57	3.37	2.07
Operating Cash Flow Less CapEx to Interest Expense	3.67	6.96	15.84	6.57	2.48	1.33
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.00	0.91	1.09	1.08	0.74	0.79
Accounts Receivable Turnover	0.00	4.36	4.88	4.87	4.34	5.04
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	10.45	13.01	15.60	12.35	13.15
Accounts Payable Turnover	0.00	21.75	26.80	28.00	22.42	27.22
Days Sales Outstanding (DSO)	0.00	83.64	74.78	74.98	84.12	72.39
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	16.78	13.62	13.04	16.28	13.41
Cash Conversion Cycle (CCC)	0.00	66.86	61.17	61.94	67.84	58.98
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	0.00	3,295	3,240	4,775	8,790	8,535
Invested Capital Turnover	0.00	2.87	1.71	1.58	1.05	1.11
Increase / (Decrease) in Invested Capital	0.00	3,295	-54	1,535	4,015	-255
Enterprise Value (EV)	0.00	0.00	9,028	8,200	10,779	7,409
Market Capitalization	0.00	0.00	8,408	6,121	6,132	2,914
Book Value per Share	$0.00	$44.61	$50.08	$52.18	$62.21	$62.32
Tangible Book Value per Share	$0.00	($6.45)	$2.89	($23.11)	($56.16)	($49.90)
Total Capital	0.00	3,447	3,422	4,920	9,085	8,775
Total Debt	0.00	1,145	802	2,224	4,942	4,736
Total Long-Term Debt	0.00	1,111	802	2,224	4,940	4,733
Net Debt	0.00	992	620	2,079	4,647	4,495
Capital Expenditures (CapEx)	111	171	149	140	181	239
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	296	393	477	492	609
Debt-free Net Working Capital (DFNWC)	0.00	448	575	622	787	849
Net Working Capital (NWC)	0.00	415	575	622	785	847
Net Nonoperating Expense (NNE)	52	25	12	25	195	249
Net Nonoperating Obligations (NNO)	0.00	992	620	2,079	4,647	4,495
Total Depreciation and Amortization (D&A)	306	277	279	311	394	731
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	6.27%	7.03%	7.54%	6.91%	6.33%
Debt-free Net Working Capital to Revenue	0.00%	9.50%	10.29%	9.84%	11.06%	8.83%
Net Working Capital to Revenue	0.00%	8.79%	10.29%	9.84%	11.03%	8.80%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$7.78	$8.34	$5.72	$3.72
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	51.36M	51.35M	53.80M	64.98M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$7.70	$8.28	$5.70	$3.71
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	51.91M	51.74M	54.01M	65.07M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	52.32M	52.07M	66.33M	64.40M
Normalized Net Operating Profit after Tax (NOPAT)	169	190	418	461	508	501
Normalized NOPAT Margin	3.58%	4.02%	7.48%	7.29%	7.15%	5.20%
Pre Tax Income Margin	4.34%	5.68%	9.95%	9.57%	5.74%	3.11%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	3.22	6.55	25.11	9.63	3.03	1.93
NOPAT to Interest Expense	1.83	3.93	18.13	6.58	2.53	1.56
EBIT Less CapEx to Interest Expense	2.01	3.00	18.64	7.64	2.13	1.19
NOPAT Less CapEx to Interest Expense	0.62	0.39	11.66	4.58	1.63	0.81
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	3.23%	12.26%	20.23%	33.36%
Augmented Payout Ratio	0.00%	0.00%	9.41%	40.57%	40.61%	87.54%

This table displays calculated financial ratios and metrics derived from Concentrix's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	8/31/2022	11/30/2022	2/28/2023	5/31/2023	8/31/2023	11/30/2023	2/29/2024	5/31/2024	8/31/2024	11/30/2024	2/28/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	13.05%	11.87%	6.53%	2.97%	3.37%	35.96%	46.83%	47.44%	46.21%	9.74%	-1.27%
EBITDA Growth	10.56%	18.30%	0.14%	0.10%	-8.07%	13.55%	50.13%	50.79%	27.04%	18.33%	-1.29%
EBIT Growth	7.88%	20.16%	-1.95%	-3.93%	-7.98%	-22.56%	1.92%	10.71%	-31.31%	28.05%	11.93%
NOPAT Growth	3.63%	-9.17%	4.00%	-0.10%	4.38%	41.52%	-8.34%	-4.77%	-18.20%	-8.95%	10.84%
Net Income Growth	-2.40%	-15.44%	-20.51%	-30.24%	-27.53%	-33.79%	-40.71%	-15.24%	-78.58%	66.43%	34.85%
EPS Growth	-1.92%	-14.83%	-19.62%	-29.44%	-26.96%	-49.25%	-54.76%	-35.10%	-83.22%	68.63%	36.84%
Operating Cash Flow Growth	64.02%	29.46%	130.80%	-20.32%	38.58%	-2.72%	-145.11%	78.62%	-9.36%	24.05%	103.00%
Free Cash Flow Firm Growth	53.05%	-885.19%	114.64%	110.72%	115.57%	-171.37%	-1,974.06%	-2,598.57%	-1,815.36%	110.47%	109.95%
Invested Capital Growth	48.83%	47.36%	-1.93%	-0.68%	-2.33%	84.09%	83.87%	82.14%	85.43%	-2.90%	-3.10%
Revenue Q/Q Growth	0.73%	3.87%	-0.26%	-1.33%	1.12%	36.62%	7.71%	-0.92%	0.28%	2.54%	-3.10%
EBITDA Q/Q Growth	4.20%	9.17%	-15.15%	3.71%	-4.30%	34.83%	12.18%	5.90%	-19.37%	25.58%	-6.41%
EBIT Q/Q Growth	6.38%	12.38%	-20.09%	0.56%	1.90%	-5.43%	5.18%	9.22%	-36.77%	76.28%	-8.06%
NOPAT Q/Q Growth	-6.68%	1.68%	0.84%	4.40%	-2.49%	37.86%	-34.69%	8.47%	-16.25%	53.45%	-20.49%
Net Income Q/Q Growth	-5.23%	-2.04%	-16.27%	-10.27%	-1.54%	-10.50%	-25.02%	28.28%	-75.12%	595.39%	-39.25%
EPS Q/Q Growth	-4.67%	-1.47%	-16.42%	-10.12%	-1.32%	-31.54%	-25.49%	28.95%	-74.49%	588.00%	-39.53%
Operating Cash Flow Q/Q Growth	-8.90%	54.49%	-55.92%	28.44%	58.44%	8.44%	-120.44%	608.51%	-19.60%	48.42%	-99.50%
Free Cash Flow Firm Q/Q Growth	-3.33%	4.56%	114.87%	-26.91%	50.18%	-1,763.12%	-2.66%	2.56%	-3.10%	110.15%	-2.38%
Invested Capital Q/Q Growth	0.25%	-2.11%	1.41%	-0.21%	-1.41%	84.50%	1.29%	-1.15%	0.37%	-3.39%	1.09%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	35.89%	36.17%	35.51%	35.93%	36.36%	36.89%	35.65%	36.02%	36.20%	35.56%	36.08%
EBITDA Margin	15.70%	16.51%	14.04%	14.76%	13.97%	13.78%	14.36%	15.09%	12.14%	14.86%	14.35%
Operating Margin	9.97%	10.85%	9.54%	10.07%	9.94%	8.09%	6.18%	6.31%	6.42%	5.90%	7.12%
EBIT Margin	10.74%	11.62%	9.31%	9.49%	9.56%	6.62%	6.46%	7.12%	4.49%	7.72%	7.33%
Profit (Net Income) Margin	6.78%	6.40%	5.37%	4.88%	4.75%	3.11%	2.17%	2.81%	0.70%	4.72%	2.96%
Tax Burden Percent	71.72%	64.55%	74.25%	74.41%	72.69%	90.11%	71.55%	76.71%	62.96%	102.43%	69.70%
Interest Burden Percent	88.05%	85.28%	77.69%	69.18%	68.42%	52.24%	46.90%	51.38%	24.63%	59.73%	58.00%
Effective Tax Rate	28.28%	35.45%	25.75%	25.59%	27.31%	9.89%	28.45%	23.29%	37.04%	-2.43%	30.30%
Return on Invested Capital (ROIC)	10.79%	11.05%	9.30%	10.00%	9.78%	7.65%	5.07%	6.14%	5.59%	6.72%	5.43%
ROIC Less NNEP Spread (ROIC-NNEP)	10.39%	10.31%	7.98%	7.95%	7.81%	4.88%	3.49%	4.69%	3.14%	6.01%	4.42%
Return on Net Nonoperating Assets (RNNOA)	5.87%	5.24%	6.12%	5.87%	5.75%	4.80%	3.46%	4.53%	2.90%	6.71%	5.10%
Return on Equity (ROE)	16.66%	16.29%	15.43%	15.87%	15.53%	12.44%	8.53%	10.67%	8.49%	13.43%	10.53%
Cash Return on Invested Capital (CROIC)	-27.67%	-26.79%	11.44%	10.22%	12.03%	-51.70%	-51.80%	-50.95%	-52.62%	8.73%	8.94%
Operating Return on Assets (OROA)	11.23%	12.54%	8.97%	9.32%	8.21%	4.91%	5.40%	6.61%	4.09%	6.07%	5.82%
Return on Assets (ROA)	7.09%	6.91%	5.17%	4.80%	4.08%	2.31%	1.81%	2.60%	0.63%	3.71%	2.35%
Return on Common Equity (ROCE)	16.66%	16.29%	15.42%	15.86%	15.53%	12.44%	8.53%	10.67%	8.49%	13.43%	10.53%
Return on Equity Simple (ROE_SIMPLE)	17.18%	0.00%	14.75%	13.27%	12.03%	0.00%	6.78%	6.52%	4.92%	0.00%	6.68%
Net Operating Profit after Tax (NOPAT)	113	115	116	121	118	163	106	115	96	148	118
NOPAT Margin	7.15%	7.00%	7.08%	7.49%	7.22%	7.29%	4.42%	4.84%	4.04%	6.05%	4.96%
Net Nonoperating Expense Percent (NNEP)	0.40%	0.74%	1.32%	2.05%	1.97%	2.77%	1.58%	1.44%	2.45%	0.71%	1.01%
Return On Investment Capital (ROIC_SIMPLE)	-	2.34%	-	-	-	1.79%	1.16%	-	-	1.69%	1.32%
Cost of Revenue to Revenue	64.11%	63.84%	64.49%	64.07%	63.64%	63.11%	64.35%	63.98%	63.80%	64.44%	63.92%
SG&A Expenses to Revenue	25.91%	25.32%	25.98%	25.87%	26.42%	28.80%	29.47%	29.71%	29.78%	29.66%	28.96%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	25.91%	25.32%	25.98%	25.87%	26.42%	28.80%	29.47%	29.71%	29.78%	29.66%	28.96%
Earnings before Interest and Taxes (EBIT)	170	191	152	153	156	148	155	170	107	189	174
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	248	271	230	238	228	307	345	359	290	364	341
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.41	2.27	2.49	1.57	1.41	1.48	1.15	0.99	1.18	0.72	0.72
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.04	0.97	1.08	0.69	0.63	0.86	0.60	0.47	0.52	0.30	0.30
Price to Earnings (P/E)	14.02	14.07	16.87	11.82	11.69	19.54	16.95	15.14	23.97	11.60	10.80
Dividend Yield	0.82%	0.87%	0.79%	1.25%	1.40%	1.22%	1.63%	1.94%	1.61%	2.76%	2.81%
Earnings Yield	7.13%	7.11%	5.93%	8.46%	8.55%	5.12%	5.90%	6.60%	4.17%	8.62%	9.26%
Enterprise Value to Invested Capital (EV/IC)	1.76	1.72	1.86	1.34	1.25	1.23	1.07	0.99	1.08	0.87	0.87
Enterprise Value to Revenue (EV/Rev)	1.40	1.30	1.40	1.00	0.91	1.52	1.21	1.01	1.02	0.77	0.78
Enterprise Value to EBITDA (EV/EBITDA)	9.11	8.31	9.12	6.54	6.15	10.74	8.51	7.09	7.39	5.48	5.57
Enterprise Value to EBIT (EV/EBIT)	13.37	12.15	13.40	9.69	9.11	17.69	15.54	13.92	16.53	11.93	11.73
Enterprise Value to NOPAT (EV/NOPAT)	18.21	17.79	19.39	13.96	12.75	21.20	18.99	17.63	19.47	14.80	14.78
Enterprise Value to Operating Cash Flow (EV/OCF)	15.72	13.65	13.65	10.31	8.69	15.90	18.05	13.84	15.64	11.10	10.48
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	16.09	13.02	10.25	0.00	0.00	0.00	0.00	9.80	9.57
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.91	0.83	0.79	0.75	1.37	1.19	1.23	1.21	1.18	1.17	1.22
Long-Term Debt to Equity	0.91	0.83	0.79	0.75	1.37	1.19	1.23	1.21	1.18	1.17	1.22
Financial Leverage	0.56	0.51	0.77	0.74	0.74	0.98	0.99	0.97	0.92	1.12	1.15
Leverage Ratio	2.26	2.20	2.41	2.36	2.74	2.80	2.73	2.69	2.92	2.99	2.97
Compound Leverage Factor	1.99	1.88	1.87	1.63	1.87	1.46	1.28	1.38	0.72	1.79	1.72
Debt to Total Capital	47.63%	45.21%	44.22%	42.75%	57.78%	54.40%	55.12%	54.67%	54.09%	53.96%	54.86%
Short-Term Debt to Total Capital	0.12%	0.00%	0.00%	0.00%	0.00%	0.03%	0.03%	0.02%	0.03%	0.03%	0.01%
Long-Term Debt to Total Capital	47.51%	45.21%	44.22%	42.75%	57.78%	54.37%	55.09%	54.66%	54.06%	53.94%	54.85%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	52.37%	54.79%	55.78%	57.25%	42.22%	45.60%	44.88%	45.33%	45.91%	46.04%	45.14%
Debt to EBITDA	2.55	2.26	2.25	2.16	4.11	4.92	4.50	3.99	3.79	3.50	3.64
Net Debt to EBITDA	2.36	2.11	2.07	2.00	1.92	4.63	4.29	3.82	3.60	3.32	3.41
Long-Term Debt to EBITDA	2.54	2.26	2.25	2.16	4.11	4.92	4.50	3.99	3.79	3.50	3.64
Debt to NOPAT	5.10	4.83	4.78	4.61	8.52	9.72	10.05	9.93	9.98	9.46	9.65
Net Debt to NOPAT	4.73	4.51	4.40	4.28	3.99	9.14	9.58	9.51	9.48	8.98	9.05
Long-Term Debt to NOPAT	5.09	4.83	4.78	4.61	8.52	9.72	10.04	9.92	9.98	9.45	9.65
Altman Z-Score	2.19	2.24	2.45	2.12	1.81	1.24	1.25	1.29	1.39	1.30	1.34
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.04%	0.04%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.67	1.55	1.76	1.74	3.54	1.38	1.56	1.54	1.57	1.42	1.65
Quick Ratio	1.49	1.36	1.57	1.54	3.34	1.05	1.21	1.18	1.20	1.09	1.30
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1,487	-1,420	211	154	232	-3,853	-3,955	-3,854	-3,974	403	394
Operating Cash Flow to CapEx	584.29%	551.40%	262.38%	414.60%	481.19%	353.72%	-83.61%	396.66%	305.39%	475.02%	2.78%
Free Cash Flow to Firm to Interest Expense	-73.38	-50.59	6.21	3.27	4.70	-54.64	-47.98	-46.74	-49.17	5.30	5.39
Operating Cash Flow to Interest Expense	7.53	8.40	3.06	2.83	4.29	3.25	-0.57	2.89	2.37	3.74	0.02
Operating Cash Flow Less CapEx to Interest Expense	6.24	6.88	1.89	2.14	3.40	2.33	-1.25	2.16	1.59	2.95	-0.67
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.05	1.08	0.96	0.98	0.86	0.74	0.84	0.93	0.91	0.79	0.79
Accounts Receivable Turnover	4.95	4.87	4.75	4.78	4.77	4.34	4.76	5.30	5.67	5.04	4.86
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	15.61	15.60	15.75	16.26	16.38	12.35	13.96	15.41	16.51	13.15	13.62
Accounts Payable Turnover	41.16	28.00	31.65	31.97	33.19	22.42	29.23	31.50	34.40	27.22	34.07
Days Sales Outstanding (DSO)	73.78	74.98	76.88	76.30	76.49	84.12	76.63	68.92	64.35	72.39	75.04
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	8.87	13.04	11.53	11.42	11.00	16.28	12.49	11.59	10.61	13.41	10.71
Cash Conversion Cycle (CCC)	64.91	61.94	65.34	64.89	65.49	67.84	64.14	57.34	53.74	58.98	64.33
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	4,878	4,775	4,842	4,832	4,764	8,790	8,904	8,802	8,834	8,535	8,628
Invested Capital Turnover	1.51	1.58	1.31	1.33	1.35	1.05	1.15	1.27	1.38	1.11	1.09
Increase / (Decrease) in Invested Capital	1,600	1,535	-95	-33	-114	4,015	4,061	3,969	4,070	-255	-276
Enterprise Value (EV)	8,600	8,200	9,003	6,452	5,945	10,779	9,516	8,747	9,580	7,409	7,502
Market Capitalization	6,368	6,121	6,961	4,474	4,084	6,132	4,714	4,029	4,915	2,914	2,908
Book Value per Share	$50.85	$52.18	$53.78	$54.82	$55.78	$62.21	$62.46	$61.88	$63.81	$62.32	$62.64
Tangible Book Value per Share	($25.96)	($23.11)	($20.23)	($18.44)	($16.65)	($56.16)	($54.85)	($53.14)	($52.02)	($49.90)	($47.56)
Total Capital	5,054	4,920	5,021	4,985	6,877	9,085	9,138	9,009	9,080	8,775	8,936
Total Debt	2,407	2,224	2,220	2,131	3,973	4,942	5,037	4,925	4,912	4,736	4,902
Total Long-Term Debt	2,401	2,224	2,220	2,131	3,973	4,940	5,034	4,924	4,909	4,733	4,901
Net Debt	2,231	2,079	2,042	1,978	1,861	4,647	4,802	4,718	4,665	4,495	4,594
Capital Expenditures (CapEx)	26	43	40	32	44	65	56	60	63	60	51
Debt-free, Cash-free Net Working Capital (DFCFNWC)	519	477	576	592	544	492	767	744	795	609	861
Debt-free Net Working Capital (DFNWC)	695	622	754	745	2,656	787	1,002	951	1,041	849	1,169
Net Working Capital (NWC)	689	622	754	745	2,656	785	999	950	1,038	847	1,168
Net Nonoperating Expense (NNE)	5.87	9.95	28	42	40	93	54	48	80	32	47
Net Nonoperating Obligations (NNO)	2,231	2,079	2,042	1,978	1,861	4,647	4,802	4,718	4,665	4,495	4,594
Total Depreciation and Amortization (D&A)	78	80	77	85	72	160	190	190	183	175	167
Debt-free, Cash-free Net Working Capital to Revenue	8.44%	7.54%	8.96%	9.14%	8.33%	6.91%	9.73%	8.61%	8.45%	6.33%	8.98%
Debt-free Net Working Capital to Revenue	11.31%	9.84%	11.74%	11.51%	40.71%	11.06%	12.71%	11.00%	11.07%	8.83%	12.19%
Net Working Capital to Revenue	11.21%	9.84%	11.74%	11.51%	40.71%	11.03%	12.68%	10.98%	11.04%	8.80%	12.19%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.05	$2.02	$1.69	$1.51	$1.50	$1.02	$0.76	$0.98	$0.25	$1.73	$1.04
Adjusted Weighted Average Basic Shares Outstanding	51.19M	51.35M	51.15M	51.18M	51.06M	53.80M	65.66M	65.27M	64.66M	64.98M	64.04M
Adjusted Diluted Earnings per Share	$2.04	$2.01	$1.68	$1.51	$1.49	$1.02	$0.76	$0.98	$0.25	$1.72	$1.04
Adjusted Weighted Average Diluted Shares Outstanding	51.55M	51.74M	51.48M	51.39M	51.21M	54.01M	65.79M	65.33M	64.75M	65.07M	64.07M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	51.67M	52.07M	52.06M	52.05M	66.60M	66.33M	65.99M	65.33M	64.82M	64.40M	63.88M
Normalized Net Operating Profit after Tax (NOPAT)	113	115	116	121	118	163	106	115	96	101	118
Normalized NOPAT Margin	7.15%	7.00%	7.08%	7.49%	7.22%	7.29%	4.42%	4.84%	4.04%	4.13%	4.96%
Pre Tax Income Margin	9.46%	9.91%	7.23%	6.56%	6.54%	3.46%	3.03%	3.66%	1.11%	4.61%	4.25%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	8.37	6.79	4.48	3.24	3.17	2.09	1.88	2.06	1.33	2.48	2.38
NOPAT to Interest Expense	5.57	4.09	3.41	2.56	2.39	2.31	1.29	1.40	1.19	1.95	1.61
EBIT Less CapEx to Interest Expense	7.08	5.27	3.32	2.56	2.28	1.17	1.20	1.33	0.55	1.70	1.69
NOPAT Less CapEx to Interest Expense	4.29	2.57	2.24	1.88	1.50	1.39	0.61	0.67	0.42	1.16	0.92
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	11.48%	12.26%	13.23%	14.76%	16.37%	20.23%	25.10%	28.50%	39.89%	33.36%	31.77%
Augmented Payout Ratio	41.04%	40.57%	45.51%	35.98%	32.38%	40.61%	52.30%	70.34%	100.18%	87.54%	83.84%

Key Financial Trends

Concentrix Q1 2025 Results and Trends

In Q1 2025, Concentrix reported $2.372 billion in revenue, down 1.3% year-over-year, while operating income rose to $168.9 million (7.1% margin). Net income reached $70.3 million, up 34.8%, driving EPS of $1.04, a 36.8% gain. Free cash flow to firm improved to $393.7 million. Balance sheet leverage remains moderate with net debt/EBITDA around 3.4x, and valuation metrics look attractive, with a P/E of 10.8x versus ~16.9x a year ago.

Net income grew 34.8% y/y to $70.3 million, lifting EPS 36.8% to $1.04
Operating income margin improved to 7.1% from 6.2% a year ago
Free cash flow to firm increased to $393.7 million vs. $211 million in Q1 2024
Valuation looks attractive: P/E of 10.8x and P/B of 0.72x
Net debt/EBITDA around 3.4x, in line with peers
Revenue slightly declined 1.3% y/y to $2.372 billion
Capital expenditures steady at $50.6 million to support growth
Operating cash flow nearly flat at $1.4 million, down from $284 million in Q4 2024
Issued $682.5 million in debt in Q1, increasing financing costs
Cash conversion cycle remains elevated at ~64 days

06/23/25 04:02 AMAI Generated. May Contain Errors.

Frequently Asked Questions About Concentrix's Financials

When does Concentrix's financial year end?

According to the most recent income statement we have on file, Concentrix's fiscal year ends in November. Their fiscal year 2024 ended on November 30, 2024.

How has Concentrix's net income changed over the last 5 years?

Concentrix's net income appears to be on an upward trend, with a most recent value of $251.22 million in 2024, rising from $117.16 million in 2019. The previous period was $313.84 million in 2023. Check out Concentrix's forecast to explore projected trends and price targets.

What is Concentrix's operating income?

Concentrix's total operating income in 2024 was $596.39 million, based on the following breakdown:

Total Gross Profit: $3.45 billion
Total Operating Expenses: $2.85 billion

How has Concentrix's revenue changed over the last 5 years?

Over the last 5 years, Concentrix's total revenue changed from $4.71 billion in 2019 to $9.62 billion in 2024, a change of 104.3%.

How much debt does Concentrix have?

Concentrix's total liabilities were at $7.95 billion at the end of 2024, a 4.8% decrease from 2023, and a 176.5% increase since 2020.

How much cash does Concentrix have?

In the past 4 years, Concentrix's cash and equivalents has ranged from $145.38 million in 2022 to $295.34 million in 2023, and is currently $240.57 million as of their latest financial filing in 2024.

How has Concentrix's book value per share changed over the last 5 years?

Over the last 5 years, Concentrix's book value per share changed from 0.00 in 2019 to 62.32 in 2024, a change of 6,232.3%.

Related Companies

This page (NASDAQ:CNXC) was last updated on 6/23/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Concentrix (CNXC) Financials

Key Financial Trends

Frequently Asked Questions About Concentrix's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Concentrix (CNXC) Financials

Annual Income Statements for Concentrix

Quarterly Income Statements for Concentrix

Annual Cash Flow Statements for Concentrix

Quarterly Cash Flow Statements for Concentrix

Annual Balance Sheets for Concentrix

Quarterly Balance Sheets for Concentrix

Annual Metrics And Ratios for Concentrix

Quarterly Metrics And Ratios for Concentrix

Key Financial Trends

Frequently Asked Questions About Concentrix's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools